The $21.32 Value Of Fusion Pharmaceuticals Inc (NASDAQ: FUSN) Should Not Be Underestimated
During the last session, Fusion Pharmaceuticals Inc (NASDAQ:FUSN)’s traded shares were 4.51 million, with the beta value of the company hitting -0.71. At the end